Synopsis

This talk is about advanced body composition assessment methods using MRI and MRS. Approaches for automation and standardization across different scanner platforms will be discussed. Recent advancements in understanding how biomarkers for liver and muscle steatosis links to incidence and progression of metabolic disorders such as diabetes mellitus and coronary heart disease will be reviewed. By applying whole body MRI in large scale population studies, new phenotypes can be described connecting skewness in body fat distribution to specific comorbidity patterns. Further, it will be discussed how detailed volumetric description of muscles can advance our understanding of muscle degeneration and sarcopenia.